Page last updated: 2024-08-23

pirimiphos methyl and cgp-56697

pirimiphos methyl has been researched along with cgp-56697 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aerts, A; Bennett, A; Didier, B; Dufour, MK; Gani, Z; Gosling, R; Greenhouse, B; Hsiang, MS; Katokele, S; Kleinschmidt, I; McCreesh, P; Medzihradsky, OF; Mumbengegwi, D; Ntuku, H; Prach, LM; Roberts, KW; Smith, J; Sturrock, H; Tambo, M; Uusiku, P1

Trials

1 trial(s) available for pirimiphos methyl and cgp-56697

ArticleYear
Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
    BMJ open, 2018, 01-27, Volume: 8, Issue:1

    Topics: Adult; Animals; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Child; Drug Combinations; Ethanolamines; Female; Fluorenes; Humans; Insecticides; Malaria; Male; Mass Drug Administration; Mosquito Control; Mosquito Vectors; Namibia; Organothiophosphorus Compounds; Research Design; Residence Characteristics

2018